Bioventus Inc (BVS)
11.12
-0.04
(-0.31%)
USD |
NASDAQ |
Nov 14, 16:00
11.12
0.00 (0.00%)
After-Hours: 18:19
Bioventus Net Income (TTM): -39.48M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | -39.48M |
| June 30, 2024 | -41.96M |
| March 31, 2024 | -21.65M |
| December 31, 2023 | -156.23M |
| September 30, 2023 | -182.06M |
| June 30, 2023 | -283.01M |
| March 31, 2023 | -286.58M |
| December 31, 2022 | -158.70M |
| September 30, 2022 | -127.14M |
| June 30, 2022 | -19.96M |
| Date | Value |
|---|---|
| March 31, 2022 | -16.84M |
| December 31, 2021 | 19.38M |
| September 30, 2021 | 22.52M |
| June 30, 2021 | 32.04M |
| March 31, 2021 | 30.40M |
| December 31, 2020 | 16.41M |
| September 30, 2020 | 19.27M |
| June 30, 2020 | 4.766M |
| March 31, 2020 | -10.49M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-286.58M
Minimum
Mar 2023
32.04M
Maximum
Jun 2021
-63.12M
Average
-19.96M
Median
Jun 2022
Net Income (TTM) Benchmarks
| Boston Scientific Corp | 1.789B |
| Insulet Corp | 420.90M |
| Perspective Therapeutics Inc | -59.02M |
| Xtant Medical Holdings Inc | -3.333M |
| Catheter Precision Inc | -9.491M |